Frankly Speaking About Family Medicine Podcast

Hosted ByPri-Med

Translating today's clinical research and news into tomorrow's practice.
Each episode of this podcast series, hosted by Frank J. Domino, MD, Professor in the Department of Family Medicine and Community Health at UMass Medical School, will feature interviews with family physicians about practice-changing clinical research and cover patient-focused best practices in Family Medicine.

Website Subscribe

Frankly Speaking About Family Medicine New Benefits Give SGLT2 Inhibitors Their Turn to Shine – Frankly Speaking Ep 376

15 de abril de 2024 casimedicos Frankly Speaking About Family Medicine Podcast 00:08:15 0 Comments

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-376

Overview: While GLP-1 agents are center stage in the medical and lay press, drugs in the class of sodium-glucose cotransporter 2 inhibitors (SGLT2is) are also quite remarkable at improving a variety of health endpoints. This episode provides an overview of studies supporting the use of SGLT2is to improve patient outcomes.

Episode resource links:

  • DM/HF:  Age Ageing 2024 Jan 2;53(1):afad254. doi: 10.1093/ageing/afad254
  • Kidney stones: JAMA Intern Med. 2024 Jan 29:e237660. doi: 10.1001/jamainternmed.2023.7660

Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.